Compare SSEA & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSEA | GOSS |
|---|---|---|
| Founded | 2024 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.9M | 88.6M |
| IPO Year | N/A | 2018 |
| Metric | SSEA | GOSS |
|---|---|---|
| Price | $10.23 | $0.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $4.19 |
| AVG Volume (30 Days) | 2.2K | ★ 12.7M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $48,471,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $201.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.94 | $0.16 |
| 52 Week High | $10.29 | $3.87 |
| Indicator | SSEA | GOSS |
|---|---|---|
| Relative Strength Index (RSI) | 62.23 | 25.51 |
| Support Level | N/A | $0.16 |
| Resistance Level | $10.29 | $0.36 |
| Average True Range (ATR) | 0.01 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 100.00 | 4.15 |
Starry Sea Acquisition Corp is a newly organized blank check company.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).